DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Sodium propionate is an investigational drug.
There have been 4 clinical trials for Sodium propionate. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 1993.
The most common disease conditions in clinical trials are Asthma, Lung Diseases, and Bronchiolitis Obliterans. The leading clinical trial sponsors are National Heart, Lung, and Blood Institute (NHLBI), Lee, Stephanie, and National Cancer Institute (NCI).
Recent Clinical Trials for Sodium propionate
|Targeted Therapy of Bronchiolitis Obliterans Syndrome||National Cancer Institute (NCI)||Phase 2|
|Targeted Therapy of Bronchiolitis Obliterans Syndrome||Lee, Stephanie||Phase 2|
|Montelukast Asthmatic Smoker Study (0476-332)(COMPLETED)||Merck Sharp & Dohme Corp.||Phase 3|